Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For MSF.BR
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q1 Q2 Δ in %
Current Ratio -26.78 1.22 1.66
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 296.28 2.72 0.69
Naive Interpretation member
2 Per Share
Metric Q1 Q2 Δ in %
Book Value 7.82 31.92 29.61
Cash -43.81 10.85 19.31
Capex 1.95 -1.30 -1.33
Free Cash Flow -55.93 1.22 2.77
Revenue 9.60 8.31 7.58
Naive Interpretation member
3 Profitability
Metric Q1 Q2 Δ in %
Gross Margin -3.93 0.68 0.71
Operating Margin -8.41 0.44 0.48
ROA -7.05 0.05 0.05
ROE -9.12 0.09 0.10
ROIC -5.29 0.06 0.07
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of MSF.BR is permitted for members.
5 Growth
The "Growth Entry" for the Focus of MSF.BR is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of MSF.BR is permitted for members.